BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32462251)

  • 21. Editorial: Approaches to Advance Cancer Vaccines to Clinical Utility.
    Van Nuffel AMT; Boudousquié C; Tuyaerts S
    Front Immunol; 2019; 10():2032. PubMed ID: 31507617
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic cancer vaccines.
    Acres B; Paul S; Haegel-Kronenberger H; Calmels B; Squiban P
    Curr Opin Mol Ther; 2004 Feb; 6(1):40-7. PubMed ID: 15011780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Tumor Antigens and Cancer Immunotherapy.
    Vigneron N
    Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination for melanoma.
    Thompson LW; Brinckerhoff L; Slingluff CL
    Curr Oncol Rep; 2000 Jul; 2(4):292-9. PubMed ID: 11122856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic cancer vaccines: using unique antigens.
    Lewis JJ
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14653-6. PubMed ID: 15297620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of vaccine-induced T cells in humans with cancer.
    Slezak SL; Worschech A; Wang E; Stroncek DF; Marincola FM
    Adv Exp Med Biol; 2010; 684():178-88. PubMed ID: 20795549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer vaccines: Tumor-associated antigens
    Wagner S; Mullins CS; Linnebacher M
    World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell response to unique and shared antigens and vaccination of cancer patients.
    Parmiani G; Sensi M; Castelli C; Rivoltini L; Anichini A
    Cancer Immun; 2002 Jun; 2():6. PubMed ID: 12747751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccines against advanced melanoma.
    Blanchard T; Srivastava PK; Duan F
    Clin Dermatol; 2013; 31(2):179-90. PubMed ID: 23438381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma vaccines: mixed past, promising future.
    Ozao-Choy J; Lee DJ; Faries MB
    Surg Clin North Am; 2014 Oct; 94(5):1017-30, viii. PubMed ID: 25245965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic vaccination with tumor cells that engage CD137.
    Hellstrom KE; Hellstrom I
    J Mol Med (Berl); 2003 Feb; 81(2):71-86. PubMed ID: 12601523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic vaccination for the treatment of malignant melanoma.
    Walden P
    Recent Results Cancer Res; 2007; 176():219-27. PubMed ID: 17607929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The present status and future prospects of peptide-based cancer vaccines.
    Hirayama M; Nishimura Y
    Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized cancer vaccines: adjuvants are important, too.
    Gouttefangeas C; Rammensee HG
    Cancer Immunol Immunother; 2018 Dec; 67(12):1911-1918. PubMed ID: 29644387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer immunotherapy: moving forward with peptide T cell vaccines.
    Kumai T; Fan A; Harabuchi Y; Celis E
    Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines against cancer: Despite setbacks, attempts to harness the patient's immune system to fight tumor cells show promise in clinical trials.
    Hunter P
    EMBO Rep; 2014 May; 15(5):485-8. PubMed ID: 24743446
    [No Abstract]   [Full Text] [Related]  

  • 37. Melanoma vaccines: achievements and perspectives.
    Brichard VG; Gérard C
    Forum (Genova); 2003; 13(2):144-54; quiz 189. PubMed ID: 14732881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants.
    Pampena MB; Cartar HC; Cueto GR; Levy EM; Blanco PA; Barrio MM; Mordoh J
    Front Immunol; 2018; 9():2531. PubMed ID: 30450100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
    Esquerré M; Momot M; Goubier A; Gonindard C; Leung-Theung-Long S; Misseri Y; Bissery MC
    Vaccine; 2017 Mar; 35(11):1509-1516. PubMed ID: 28196735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer vaccines.
    Butterfield LH
    BMJ; 2015 Apr; 350():h988. PubMed ID: 25904595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.